Login / Signup

Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice.

Heike WeidnerManja WobusLorenz C HofbauerMartina RaunerUwe Platzbecker
Published in: Leukemia (2022)
Keyphrases
  • bone loss
  • acute myeloid leukemia
  • high fat diet induced
  • bone marrow
  • estrogen receptor
  • replacement therapy
  • insulin resistance
  • wild type